Update in the management of extraintestinal manifestations of inflammatory bowel disease.
Inflammatory bowel disease, comprised of Crohn's disease and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract. Up to 40 % of patients with inflammatory bowel disease can develop inflammation in other organ systems of the body. These extraintestinal manifestations (EIM) can affect the musculoskeletal, ocular, mucocutaneous, and hepatobiliary systems. Symptoms related to EIM can result in impaired quality of life, and complications of EIM can lead to disfigurement, functional deficits, and even life-threatening organ dysfunction. Some EIM parallel the activity of IBD, and respond to treatment of the underlying disease. Others, however, follow an independent course and require targeted treatment.
University of Maryland School of Medicine, Baltimore, MD, USA. spatil@medicine.umaryland.edu
Seema A
SA
Patil
Raymond K
RK
Cross
D015209:Cholangitis, Sclerosing / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D020022:Genetic Predisposition to Disease; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D015423:Scleritis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D014605:Uveitis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy